HOUSE COMMITTEE EXAMINES FLU VACCINE SHORTAGE

Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases, appears before the House Government Reform Committee to discuss the nation's flue vacine shortage on Capitol Hill in Washington on Oct. 8, 2004. The supply of flu shots was dramatically cut after a major manufacturer in Great Britain was forced to pull its vaccine due to bacterial contamination. (UPI Photo/Roger L. Wollenberg)

License photo

Rate:

Email this to a friend

AIDS experts go back to basics

WASHINGTON, March 26 (UPI) -- The head of the U.S. agency in charge of AIDS research says scientists need to go back to basics to find a vaccine against the HIV virus.

New understanding of how HIV works

SAN FRANCISCO, Feb. 11 (UPI) -- U.S. government scientists have discovered an important piece of the puzzle in their efforts to learn how the human immunodeficiency virus operates.

Dengue potential U.S. health threat

WASHINGTON , Jan. 9 (UPI) -- U.S. researchers said public health officials need to consider the threat of dengue reaching the United States as a real possibility.

Puzzling results from HIV vaccine trial

WASHINGTON, Dec. 3 (UPI) -- A potential HIV vaccine that recently failed a clinical trial in the United States may increase some people's chance of catching the virus that causes AIDS.

Scientists gain new view of immunity

WASHINGTON, April 17 (UPI) --

Flu vaccine supplies seen as adequate

WASHINGTON, Oct. 25 (UPI) --

U.S. looking for weapons against bird flu

BETHESDA, Md., Oct. 4 (UPI) -- The United States has begun stockpiling antiviral drugs and awarding contracts to develop vaccines in response to warnings of an avian influenza pandemic.